Stem cell-based therapeutic preparations for medical use; progenitor cell-based therapeutic preparations for medical use; cellular therapeutic preparations derived from cardiac progenitor cells; biologic therapeutic preparations derived from neonatal stem cells and neonatal progenitor cells for medical use; pharmaceutical preparations for the treatment of cardiovascular diseases and disorders, including heart failure, cardiomyopathy, and genetic cardiomyopathies; pharmaceutical preparations f...